La taille du marché des emballages parentéraux pharmaceutiques est évaluée à 13,20 milliards USD en 2023 et devrait atteindre 18,81 milliards USD d'ici 2032, avec un TCAC de 4,45 % au cours de la période de prévision de 2024 à 2032.
L'emballage parentéral pharmaceutique englobe des techniques spécialisées conçues pour stocker et administrer des produits pharmaceutiques stériles par perfusion, injection intramusculaire ou épidermique, en contournant le tube digestif. Ces solutions d'emballage garantissent que le produit reste intact, stérile et sûr tout au long de son cycle de vie, du stockage et du transport à l'administration. Le marché connaît une croissance tirée par la prévalence croissante des maladies chroniques, l'utilisation croissante de médicaments injectables, l'attention accrue portée à la sécurité des patients et l'adoption croissante de produits biologiques, de seringues préremplies et de dispositifs d'injection. Ces facteurs devraient augmenter la demande de solutions d'emballage parentéral pharmaceutique et soutenir l'expansion du marché.
Cependant, la croissance du marché devrait être confrontée à des défis en raison des réglementations et normes gouvernementales strictes, ainsi que des coûts élevés des matières premières utilisées dans les emballages parentéraux pharmaceutiques.
Attribut de rapport | Caractéristiques |
Taille du marché Valeur en 2023 | 13,20 milliards USD |
Prévisions de revenus en 2032 | 18,81 milliards USD |
Taux de croissance TCAC | TCAC de 4,45 % de 2024 à 2032 |
Unités quantitatives | Représentation des revenus en millions de dollars américains et TCAC de 2024 à 2032 |
Année historique | 2019 à 2023 |
Année de prévision | 2024-2032 |
Couverture du rapport | Les prévisions de revenus, la position de l'entreprise, la structure concurrentielle du marché, les perspectives de croissance et les tendances |
Par type |
|
Par application |
|
Par région |
|
Portée de la personnalisation | Rapport de personnalisation gratuit avec l'obtention du rapport et les modifications de la portée régionale et sectorielle. Paysage concurrentiel géographique particulier. |
Paysage concurrentiel | Adelphi Healthcare Packaging, Akorn, Inc., Alcami Corporation, Inc., Ardena Holding NV, Baxter International Inc., Becton, Dickinson and Company, Berkshire Sterile Manufacturing, Berry Global Inc., Catalent Inc., Gerresheimer AG, Nipro Corporation, PCI Pharma Services, Schott AG, SGD Pharma, SiO2 Materials Science, Stevanato Group S.p.A, Terumo Corporation, UDG Healthcare Plc., West Pharmaceutical Services, Inc., Ypsomed Holding AG. |
Pharma Parenteral Packaging Market size is valued at USD 13.20 Billion in 2023 and is projected to reach USD 18.81 Billion by 2032.
The market is expected to grow at a CAGR of 4.45% from 2024 to 2032.
Major key players include Adelphi Healthcare Packaging, Akorn, Inc., Alcami Corporation, Inc., and others.
January 2024: SCHOTT Pharma expanded its global manufacturing network by investing a double-digit million euros in a new production site for pharma drug containment solutions and delivery systems in Jagodina, central Serbia.
October 2023: Gerresheimer launched COP (Cyclic Olefin Polymer) to fill and store sensitive biopharmaceutical mRNA active ingredients.
2023: B.D. introduced the all-in-one prefilled flush syringe with an integrated disinfection unit.
The prefilled syringes segment is anticipated to be a major contributor to the pharma parenteral packaging market. The segment's growth is driven by the ease of use of prefilled syringes, their preference for small molecules over other dosage forms, lower dosage errors, and the rising demand for prefilled insulin syringes due to the increasing incidence of diabetes.
Glass Material SegmentThe glass segment is expected to witness rapid growth, primarily due to glass's impermeable and non-porous nature, which helps retain product composition. Glass also protects items from ultraviolet radiation, ensuring longer freshness, particularly in countries like the US, Germany, the UK, China, and India.
North America holds a significant revenue share in the pharma parenteral packaging market. This is attributed to the presence of prominent parenteral packaging companies, the increasing demand for injectable medication packaging, and the overall growth of the pharmaceutical industry in the region.
Asia-PacificThe Asia-Pacific region is projected to grow at the highest rate during the study period. The growth is driven by the increasing incidence of chronic and infectious diseases, the rising need for pharmaceutical vial packaging, and the expansion of vaccination programs.
The Pharma Parenteral Packaging Market is poised for significant growth driven by the increasing demand for safe and sterile pharmaceutical packaging solutions. Despite challenges such as stringent regulations and high raw material costs, advancements in packaging technologies and the growing adoption of biologics and injectable drugs are expected to support market expansion. The competitive landscape features key players continuously innovating to meet evolving market needs, ensuring the safe and effective delivery of pharmaceutical products.
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.